Health

From the Conversation with Tyler podcast with Sheilagh Ogilvie: [Ogilvie]: Historically, there was another reason, which was the medical guilds — the equivalent of the American Medical Association, only much, much worse, back in early modern Europe did not like the idea of this new thing, this new technology that they had not approved and that was…

Healthcare Economist was once again named one of the Top 10 Health Economics Blogs and Websites in 2025 (#4) by Feedspot. Feedspot also named this blog as a top 50 Best Public Health Blogs and Websites in 2025 (#13). Exciting to keep the blogging going into the future!

That is the title of a new FTI Consulting white paper co-authored with Kyi-Sin Than. The abstract is below. In October 2023, ICER released a special assessment aimed at influencing CMS drug price negotiations for two direct-acting oral anticoagulants (DOACs) selected in the first round of Inflation Reduction Act (IRA) price negotiations in 2024: Eliquis®…

That is the title of a new paper with Shanshan Wang, Jaehong Kim, and Slaven Sikirica that has the subtitle “Budget impact analysis from the US payer perspective.” That abstract is below: BACKGROUND:Heart failure (HF) is a leading cause of mortality in the United States, often complicated by comorbidities like diabetes mellitus. These patients face…

Measles outbreak expands to 19 states. Commercial health plan coverage of accelerated approval drugs…and a recent case study. Extending IRA drug price negotiation to commercial plans? ‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study’ Why are LLMs so good at economics? Most expensive states to start a business.